Latest Articlesddd
Novo Nordisk in the NEWS Novo Nordisk (NVO) presented the full results from STRIDE, a phase …
Stock Market Plummet and Alnylam Pharmaceuticals Good News Today, the stock market is plummeting. In fact, …
Wave Life Sciences On March 26, 2025, Wave Life Sciences (WVE) announced positive data from the …
BridgeBio Pharma Today, March 24, 2025, BridgeBio Pharma, Inc. (BBIO) announced that cardiovascular outcomes data in patients …
PTC Therapeutics Inc On March 20, 2025, PTC Therapeutics, Inc. (PTCT) shared new data from the Phase 3 APHENITY …
Alnylam Pharmaceuticals in the NEWS March 20, 2025, Alnylam Pharmaceuticals (ALNY) - the leading RNAi therapeutics company, …
Pyxis Oncology in the NEWS Pyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results …
Altimmune Altimmune (ALT) stock soared last Friday after speculation of a takeover by three large companies. …
With a bad market and a lot of talk about recession and shutting down the Government, …
AstraZeneca AstraZeneca (AZN) has positive high-level results from the MATTERHORN Phase III trial, which showed perioperative …
ARS Pharmaceuticals SAN DIEGO, March 05, 2025 (GLOBE NEWSWIRE), ARS Pharmaceuticals (SPRY) announced that the U.S. …
Moderna On February 28, 2025, Moderna (MRNA) announced that the Medicines and Healthcare products Regulatory Agency …
Jazz Pharmaceuticals to Acquire Chimerix Today, March 5, 2025, Jazz Pharmaceuticals (JAZZ) and Chimerix (CMRX) announced the companies …
AstraZeneca and Daiichi Sankyo AstraZeneca (AZN) and Daiichi Sankyo’s (DSKYF) (trastuzumab deruxtecan) has been recommended for approval …
Sanofi New Data Paris, February 28, 2025, Sanofi (SNY) will present 26 abstracts, including one late-breaking presentation …
Cassava Sciences in the NEWS Cassava Sciences, Inc. (SAVA) announced that it entered into an agreement …
– Showcases multiple potentially transformative near- and mid-stage therapies in ATTR amyloidosis, cardiovascular disease, and Neuroscience, …
Verona Pharma Conference Announcements Verona Pharma (VRNA) announces that senior management will present a company overview …
Gilead Sciences On February 20, 2025, Gilead Sciences (GILD) announced that the European Commission (EC) granted …
Alnylam Pharmaceuticals Questions & Answers Q: Why has Alnylam Pharmaceuticals’ stock plummeted recently? A: We do …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
